Livzon Pharmaceutical Group (HKSE:01513) Market Cap : HK$34,561 Mil (As of May. 22, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Livzon Pharmaceutical Group Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Livzon Pharmaceutical Group's share price for the quarter that ended in Mar. 2024 was HK$26.65. Livzon Pharmaceutical Group's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 927 Mil. Therefore, Livzon Pharmaceutical Group's market cap for the quarter that ended in Mar. 2024 was HK$24,695 Mil.

Livzon Pharmaceutical Group's quarterly market cap declined from Sep. 2023 (HK$23,997 Mil) to Dec. 2023 (HK$22,313 Mil) but then increased from Dec. 2023 (HK$22,313 Mil) to Mar. 2024 (HK$24,695 Mil).

Livzon Pharmaceutical Group's annual market cap declined from Dec. 2021 (HK$26,729 Mil) to Dec. 2022 (HK$24,558 Mil) and declined from Dec. 2022 (HK$24,558 Mil) to Dec. 2023 (HK$22,313 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Livzon Pharmaceutical Group's Enterprise Value for Today is HK$26,137 Mil.

Livzon Pharmaceutical Group Market Cap Historical Data

The historical data trend for Livzon Pharmaceutical Group's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Market Cap Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

22,668.00

28,392.29

26,729.15

24,558.27

22,313.10

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															25,914.82	25,213.15	23,996.93	22,313.10	24,695.09

Competitive Comparison of Livzon Pharmaceutical Group's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Livzon Pharmaceutical Group's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Market Cap distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Market Cap falls into.

Livzon Pharmaceutical Group Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Livzon Pharmaceutical Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	HK$24.15	*	923.938
	=	HK$22,313

Livzon Pharmaceutical Group's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	HK$26.65	*	926.645
	=	HK$24,695

Livzon Pharmaceutical Group (HKSE:01513) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Livzon Pharmaceutical Group Market Cap Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (HKSE:01513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (HKSE:01513) » Definitions » Market Cap

Traded in Other Exchanges

LP6:Germany 000513:China

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (HKSE:01513) Headlines

No Headlines